← Back to Search

Implantable Cardioverter Defibrillator

Subcutaneous ICD vs Transvenous ICD for Ventricular Arrhythmia (PRAETORIAN Trial)

N/A
Waitlist Available
Led By Reinoud E Knops, MD, PhD
Research Sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 months
Awards & highlights

PRAETORIAN Trial Summary

This trial will compare the two types of ICDs to see which is better.

Eligible Conditions
  • Ventricular Arrhythmia

PRAETORIAN Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants with implantable cardioverter defibrillator (ICD) related adverse events
Secondary outcome measures
Heart
Cardiac decompensation
Cross-overs to the other arm
+10 more

PRAETORIAN Trial Design

2Treatment groups
Active Control
Group I: Subcutaneous ICDActive Control1 Intervention
Subcutaneous Implantable Cardioverter Defibrillator
Group II: Transvenous ICDActive Control1 Intervention
Transvenous Implantable Cardioverter Defibrillator

Find a Location

Who is running the clinical trial?

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Lead Sponsor
664 Previous Clinical Trials
2,676,035 Total Patients Enrolled
4 Trials studying Ventricular Arrhythmia
11,475 Patients Enrolled for Ventricular Arrhythmia
Boston Scientific CorporationIndustry Sponsor
719 Previous Clinical Trials
932,548 Total Patients Enrolled
4 Trials studying Ventricular Arrhythmia
1,826 Patients Enrolled for Ventricular Arrhythmia
Reinoud E Knops, MD, PhDPrincipal InvestigatorAcademic Medical Center - University of Amsterdam (AMC-UvA)
2 Previous Clinical Trials
995 Total Patients Enrolled
2 Trials studying Ventricular Arrhythmia
995 Patients Enrolled for Ventricular Arrhythmia

Media Library

Implantation of subcutaneous ICD (Implantable Cardioverter Defibrillator) Clinical Trial Eligibility Overview. Trial Name: NCT01296022 — N/A
Ventricular Arrhythmia Research Study Groups: Subcutaneous ICD, Transvenous ICD
Ventricular Arrhythmia Clinical Trial 2023: Implantation of subcutaneous ICD Highlights & Side Effects. Trial Name: NCT01296022 — N/A
Implantation of subcutaneous ICD (Implantable Cardioverter Defibrillator) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01296022 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this medical study being conducted in various locations across the state?

"Recruitment is currently open at 10 different medical sites, including Columbus, Englewood and Ridgewood. It would be beneficial to select the closest trial site so as to minimize travel requirements if you decide to join this study."

Answered by AI

Does this experiment have any room for new participants?

"Clinicaltrials.gov confirms that this trial, first posted on February 1st 2011 and most recently updated August 6th 2020 is no longer recruiting volunteers; however, 81 other medical studies are actively enrolling research participants at the present moment."

Answered by AI
Recent research and studies
~60 spots leftby Apr 2025